SIETES :: 93212 citas

Resultados de la búsqueda por PARADIGM-HF

1.

Simó Miñana J. Guerras médicas: a propósito del ensayo EXCEL . Salud, dinero y atención primaria 2019:15 de diciembre. [Ref.ID 103225]

2.

Anónimo. Sacubitril/valsartan for chronic heart failure. Australian Prescriber 2016;39:221. [Ref.ID 101024]

3.

Anónimo. Sacubitril + valsartan et insuffisance cardiaque chronique. Prescrire 2016;36:645-50. [Ref.ID 100816]

4.

Desai AS, Claggett BL, Packer M, Zile MR, Rouleau JL, Swedberg K, Shi V, Kefkowitz M, Starling R, Teerlink J, McMurray JJV, Solomon SD, for the PARADIGM-HF Investigators. Influenze of sacubitril/valsartan (LCZ696) on 30-day readmission after heart failure hospitalization. J Am Coll Cardiol 2016;68:1-8. [Ref.ID 100489]

5.

Anónimo. Sacubitril valsartan for heart failure. Drug Ther Bull 2016;54:66-9. [Ref.ID 100402]

6.

Wise J. NICE approves innovative treatment for moderate to severe heart failure. BMJ 2016;353:i2402. [Ref.ID 100374]

7.

Yancy CW, Jessup M, Chair V, Bozkurt B, Butler J, Casey Jr DE, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lundenfeld JA, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure . Circulation 2016:1-46. [Ref.ID 100318]

8.

Feldman AM, Haller JA, DeKosky ST. Valsartan/sacubitril for heart failure: reconciling disparities between preclinical and clinical investigations. JAMA 2016;315:25-6. [Ref.ID 100122]

9.

Anónimo. Sacubitril/valsartan (Entresto) for heart failure. Med Lett Drugs Ther 2015;57:107-9. [Ref.ID 99650]

10.

Kelley KK. New heart failure drug combo approved. Journal Watch 2015:1. [Ref.ID 99246]

11.

McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, for the PARADIGM-HF Investigators and Committees. Angiotensin - Neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004. [Ref.ID 98476]

12.

Jessup M, Komajda FM, McMurray JJV, Packer M. Perspective roundtable: PARADIGM-HF - The experts' discussion. N Engl J Med 2014;371:e15. [Ref.ID 98475]

13.

McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, for the PARADIGM-HF Investigators and Committees. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004. [Ref.ID 98005]